Juslina DM: A Comprehensive Diabetes Management Solution

Juslina DM is a once-daily tablet formulated with a triple therapy of Dapagliflozin, Linagliptin, and Metformin. This combination offers a comprehensive approach to managing Type 2 diabetes, aiming for optimal glycemic control.

Key Features:

* Dapagliflozin (10mg): A sodium-glucose cotransporter 2 (SGLT2) inhibitor that enhances glucose excretion in the urine, helping lower blood sugar levels.
* Linagliptin (5mg): A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin hormone activity, further stimulating insulin release and lowering blood sugar.
* Metformin (500mg): A first-line medication for type 2 diabetes, it lowers blood glucose by increasing insulin sensitivity and reducing hepatic glucose production.

Juslina DM offers a simplified and effective solution for managing Type 2 Diabetes by combining these three powerful components. This formulation is designed to be taken once daily, making it convenient for patients.

Note: Consult your healthcare provider before starting any new medication or dosage change. Always follow the instructions provided by your doctor or pharmacist.